Other Financial Information (Tables)

12 Months Ended

Dec. 31, 2021

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Schedule of Other Income and Expense

Items reported in earnings include the following:

	Year Ended December 31,
	2021		2020		2019
Research and development expense	$	266.4	$	228.6	$	229.4
Depreciation expense	69.1		60.3		57.1
Rent expense	76.6		78.6		81.4
Advertising expense	26.0		28.3		30.3

Schedule of Accrued Liabilities

Items reported in accrued expenses and other liabilities include the following:

	December 31, 2021		December 31, 2020
Deferred revenue	$	238.9	$	199.6
Accrued payroll and other employee compensation	125.8		138.5
Litigation reserve (see Note 17)	—		96.6
Restructuring (see Note 4)	34.0		69.3
Operating lease liabilities (see Note 7)	42.1		42.3
Contract liabilities	52.1		36.1
Product warranty (see Note 1)	30.0		36.5
Tax Receivable Agreement (see Note 12)	100.0		—
Other	330.5		282.9
Total	$	953.4	$	901.8